Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2021-12-03 00:00:00 ET · period of report 2021-11-01 · accession 0001209191-21-067888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-03 | 2021-11-01+ | CPIX | KAZIMI A J | COB, CEO, Dir, 10% | P - Purchase | $2.75 | +395 | 5.77M | +0.0% | +$1,086 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | P | A | 15 | $2.71 | 5,769,939 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 2 | Common | Common Stock | 2021-11-16 | P | A | 15 | $2.66 | 5,769,954 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 3 | Common | Common Stock | 2021-11-17 | P | A | 15 | $2.58 | 5,769,969 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 4 | Common | Common Stock | 2021-11-18 | P | A | 15 | $2.58 | 5,769,984 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 5 | Common | Common Stock | 2021-11-19 | P | A | 15 | $2.55 | 5,769,999 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 6 | Common | Common Stock | 2021-11-22 | P | A | 15 | $2.35 | 5,770,014 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 7 | Common | Common Stock | 2021-11-23 | P | A | 15 | $2.29 | 5,770,029 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 8 | Common | Common Stock | 2021-11-24 | P | A | 35 | $2.31 | 5,770,064 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 9 | Common | Common Stock | 2021-11-26 | P | A | 35 | $2.26 | 5,770,099 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 10 | Common | Common Stock | 2021-11-29 | P | A | 35 | $2.23 | 5,770,134 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 11 | Common | Common Stock | 2021-11-12 | P | A | 15 | $2.67 | 5,769,924 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 12 | Common | Common Stock | 2021-11-11 | P | A | 15 | $2.83 | 5,769,909 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 13 | Common | Common Stock | 2021-11-10 | P | A | 15 | $2.94 | 5,769,894 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 14 | Common | Common Stock | 2021-11-09 | P | A | 15 | $3.21 | 5,769,879 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 15 | Common | Common Stock | 2021-11-30 | P | A | 35 | $4.61 | 5,770,169 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 16 | Common | Common Stock | 2021-11-05 | P | A | 15 | $2.71 | 5,769,849 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 17 | Common | Common Stock | 2021-11-04 | P | A | 15 | $2.73 | 5,769,834 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 18 | Common | Common Stock | 2021-11-03 | P | A | 15 | $2.71 | 5,769,819 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 19 | Common | Common Stock | 2021-11-02 | P | A | 15 | $2.63 | 5,769,804 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 20 | Common | Common Stock | 2021-11-01 | P | A | 15 | $2.67 | 5,769,789 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 21 | Common | Common Stock | 2021-11-08 | P | A | 15 | $2.95 | 5,769,864 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |